Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phase.
Phase of Trial: Phase III
Latest Information Update: 27 May 2016
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Zeria
- 05 Nov 2010 New trial record.